Reuters logo
BRIEF-Concordia International says commented on issuance by UK CMA of a statement of objections to Actavis UK and co's international segment
March 3, 2017 / 1:12 PM / 7 months ago

BRIEF-Concordia International says commented on issuance by UK CMA of a statement of objections to Actavis UK and co's international segment

March 3 (Reuters) - Concordia International Corp

* Says commented on issuance by UK CMA of a statement of objections to Actavis UK and co’s international segment

* Says issuance related to supply of 10mg hydrocortisone tablets in United Kingdom between 2013 and 2016

* Concordia International says statement of objections (SO) is a formal statement by CMA that it considers that a competition infringement may have occurred

* Concordia International says will review CMA’s provisional position as set out in its statement of objections and then intend to respond in detail to it

* Concordia International Corp says “we believe that conduct of amdipharm was not in breach of competition law”

* Concordia International says believe supply arrangement between Auden Mckenzie and amdipharm did not infringe competition law Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below